Brandon Couillard
Stock Analyst at Wells Fargo
(4.31)
# 304
Out of 4,829 analysts
122
Total ratings
55.42%
Success rate
14.11%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MYGN Myriad Genetics | Downgrades: Equal-Weight | $22 → $6 | $3.89 | +54.24% | 2 | May 8, 2025 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,125 → $1,200 | $1,080.98 | +11.01% | 5 | May 5, 2025 | |
| WGS GeneDx Holdings | Maintains: Equal-Weight | $105 → $78 | $59.14 | +31.89% | 3 | May 1, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $580 → $570 | $403.13 | +41.39% | 5 | Apr 24, 2025 | |
| A Agilent Technologies | Maintains: Hold | $135 → $116 | $106.93 | +8.48% | 22 | Apr 21, 2025 | |
| RVTY Revvity | Maintains: Equal-Weight | $130 → $102 | $91.25 | +11.78% | 2 | Apr 17, 2025 | |
| BRKR Bruker | Maintains: Overweight | $75 → $60 | $37.52 | +59.91% | 3 | Apr 17, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Equal-Weight | $320 → $270 | $238.68 | +13.12% | 9 | Apr 17, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Equal-Weight | $320 → $270 | $234.41 | +15.18% | 9 | Apr 17, 2025 | |
| AVTR Avantor | Maintains: Overweight | $25 → $22 | $12.02 | +83.03% | 4 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $415 → $420 | $344.06 | +22.07% | 3 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $280 → $240 | $189.73 | +26.50% | 2 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $181.88 | +42.95% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $68.64 | +16.55% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $28 → $24 | $15.36 | +56.25% | 2 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $85 | $51.63 | +64.63% | 16 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $180 | $123.20 | +46.11% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $10 | $1.99 | +403.78% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $120 | $123.84 | -3.10% | 1 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $17.59 | +30.76% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $0.70 | +1,757.14% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.51 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $2.46 | +347.15% | 2 | Oct 13, 2017 |
Myriad Genetics
May 8, 2025
Downgrades: Equal-Weight
Price Target: $22 → $6
Current: $3.89
Upside: +54.24%
Mettler-Toledo International
May 5, 2025
Maintains: Equal-Weight
Price Target: $1,125 → $1,200
Current: $1,080.98
Upside: +11.01%
GeneDx Holdings
May 1, 2025
Maintains: Equal-Weight
Price Target: $105 → $78
Current: $59.14
Upside: +31.89%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Overweight
Price Target: $580 → $570
Current: $403.13
Upside: +41.39%
Agilent Technologies
Apr 21, 2025
Maintains: Hold
Price Target: $135 → $116
Current: $106.93
Upside: +8.48%
Revvity
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $130 → $102
Current: $91.25
Upside: +11.78%
Bruker
Apr 17, 2025
Maintains: Overweight
Price Target: $75 → $60
Current: $37.52
Upside: +59.91%
Bio-Rad Laboratories
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $320 → $270
Current: $238.68
Upside: +13.12%
Bio-Rad Laboratories
Apr 17, 2025
Maintains: Equal-Weight
Price Target: $320 → $270
Current: $234.41
Upside: +15.18%
Avantor
Apr 17, 2025
Maintains: Overweight
Price Target: $25 → $22
Current: $12.02
Upside: +83.03%
Feb 13, 2025
Maintains: Overweight
Price Target: $415 → $420
Current: $344.06
Upside: +22.07%
Jan 30, 2025
Maintains: Equal-Weight
Price Target: $280 → $240
Current: $189.73
Upside: +26.50%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $181.88
Upside: +42.95%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $68.64
Upside: +16.55%
Jan 15, 2025
Upgrades: Equal-Weight
Price Target: $28 → $24
Current: $15.36
Upside: +56.25%
Nov 6, 2024
Maintains: Buy
Price Target: $84 → $85
Current: $51.63
Upside: +64.63%
Aug 27, 2024
Initiates: Overweight
Price Target: $180
Current: $123.20
Upside: +46.11%
Aug 27, 2024
Initiates: Overweight
Price Target: $10
Current: $1.99
Upside: +403.78%
Aug 27, 2024
Initiates: Underweight
Price Target: $120
Current: $123.84
Upside: -3.10%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $17.59
Upside: +30.76%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $0.70
Upside: +1,757.14%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $2.51
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $2.46
Upside: +347.15%